Literature DB >> 10601688

Desolvation process and surface characterisation of protein nanoparticles.

C Weber1, C Coester, J Kreuter, K Langer.   

Abstract

The objective of the present study was to characterise and optimise the desolvation process of human serum albumin (HSA) for the preparation of nanoparticles and to characterise the resulting colloidal system. Following the desolvation of the protein, the resulting nanoparticles were stabilised by the addition of varying amounts of glutaraldehyde or by heat denaturation. The particle size, zeta potential, and the number of available amino groups on the surface of the nanoparticles were determined. The amino groups were quantified by a spectrophotometric method using 2,4, 6-trinitrobenzenesulfonic acid (TNBS). The results indicated that the particle size depended mainly on the amount of desolvating agent added, but not on the amount of cross-linker or the kind of cross-linking procedure. Increasing amounts of glutaraldehyde reduced the number of amino groups on the surface of HSA nanoparticles and also decreased the zeta potential of the carrier system. The temperature and heat denaturation time only had an influence on the stability of the nanoparticles but not on the amount of amino groups or the particle size. It was shown that heat denatured HSA nanoparticles possessed the greatest number of amino groups on their surface. Additional experiments for the characterisation of gelatin A and B nanoparticles were performed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10601688     DOI: 10.1016/s0378-5173(99)00370-1

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  66 in total

1.  Bovine serum albumin nanoparticles with fluorogenic near-IR-emitting squaraine dyes.

Authors:  Yuanwei Zhang; Xiling Yue; Bosung Kim; Sheng Yao; Mykhailo V Bondar; Kevin D Belfield
Journal:  ACS Appl Mater Interfaces       Date:  2013-08-30       Impact factor: 9.229

2.  Nanoparticle Formulation Increases Oral Bioavailability of Poorly Soluble Drugs: Approaches Experimental Evidences and Theory.

Authors:  Lee Jia
Journal:  Curr Nanosci       Date:  2005-11-01       Impact factor: 1.824

3.  Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation.

Authors:  M M Stollenwerk; I Pashkunova-Martic; C Kremser; H Talasz; G C Thurner; A A Abdelmoez; E A Wallnöfer; A Helbok; E Neuhauser; N Klammsteiner; L Klimaschewski; E von Guggenberg; E Fröhlich; B Keppler; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2010-02-20       Impact factor: 4.304

4.  Selection of a suitable method for the preparation of polymeric nanoparticles: multi-criteria decision making approach.

Authors:  Kannan Krishnamoorthy; Manikandan Mahalingam
Journal:  Adv Pharm Bull       Date:  2015-03-05

5.  Controlling silk fibroin particle features for drug delivery.

Authors:  Andreas S Lammel; Xiao Hu; Sang-Hyug Park; David L Kaplan; Thomas R Scheibel
Journal:  Biomaterials       Date:  2010-03-09       Impact factor: 12.479

6.  5-Fluorouracil-loaded BSA nanoparticles: formulation optimization and in vitro release study.

Authors:  Amir Maghsoudi; Seyed Abbas Shojaosadati; Ebrahim Vasheghani Farahani
Journal:  AAPS PharmSciTech       Date:  2008-10-11       Impact factor: 3.246

7.  Application of albumin-based nanoparticles in the management of cancer.

Authors:  Xinzhe Yu; Chen Jin
Journal:  J Mater Sci Mater Med       Date:  2015-11-26       Impact factor: 3.896

Review 8.  Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects.

Authors:  Heidi M Mansour; Minji Sohn; Abeer Al-Ghananeem; Patrick P Deluca
Journal:  Int J Mol Sci       Date:  2010-09-15       Impact factor: 5.923

9.  Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles.

Authors:  Dongmei Zhao; Xiuhua Zhao; Yuangang Zu; Jialei Li; Yu Zhang; Ru Jiang; Zhonghua Zhang
Journal:  Int J Nanomedicine       Date:  2010-09-20

10.  The novel albumin-chitosan core-shell nanoparticles for gene delivery: preparation, optimization and cell uptake investigation.

Authors:  Mahdi Karimi; Pinar Avci; Rezvan Mobasseri; Michael R Hamblin; Hossein Naderi-Manesh
Journal:  J Nanopart Res       Date:  2013-04-01       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.